These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3338987)

  • 1. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.
    Loomis CR; Bell RM
    J Biol Chem; 1988 Feb; 263(4):1682-92. PubMed ID: 3338987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chelerythrine is a potent and specific inhibitor of protein kinase C.
    Herbert JM; Augereau JM; Gleye J; Maffrand JP
    Biochem Biophys Res Commun; 1990 Nov; 172(3):993-9. PubMed ID: 2244923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
    Robinson PJ; Cheng HC; Black CK; Schmidt CJ; Kariya T; Jones WD; Dage RC
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1392-8. PubMed ID: 2175806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoacridines, potent inhibitors of protein kinase C.
    Hannun YA; Bell RM
    J Biol Chem; 1988 Apr; 263(11):5124-31. PubMed ID: 3258596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes.
    Mahoney CW; Azzi A; Huang KP
    J Biol Chem; 1990 Apr; 265(10):5424-8. PubMed ID: 1690710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of protein kinase C subtypes.
    Pelosin JM; Keramidas M; Souvignet C; Chambaz EM
    Biochem Biophys Res Commun; 1990 Jun; 169(3):1040-8. PubMed ID: 2363714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation.
    Hallahan DE; Virudachalam S; Schwartz JL; Panje N; Mustafi R; Weichselbaum RR
    Radiat Res; 1992 Mar; 129(3):345-50. PubMed ID: 1542722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorescent protein kinase C inhibitor: 1-(1-hydroxy-5-isoquinolinylsulfonyl)piperazine.
    Hagiwara M; Inagaki M; Takahashi J; Yoshida T; Hidaka H
    Pharmacology; 1988; 36(6):365-70. PubMed ID: 3420158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [3H]staurosporine binding in protein kinase C-II purified from rat brain.
    Miyazaki A; Kitamura Y; Nomura Y
    Neurochem Int; 1993 May; 22(5):455-64. PubMed ID: 8485451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation.
    Lee SA; Jung M
    J Biol Chem; 2007 May; 282(20):15271-83. PubMed ID: 17371872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C inhibitors block insulin and PMA-stimulated hexose transport in isolated rat adipocytes and BC3H-1 myocytes.
    Standaert ML; Buckley DJ; Ishizuka T; Hoffman JM; Cooper DR; Pollet RJ; Farese RV
    Metabolism; 1990 Nov; 39(11):1170-9. PubMed ID: 2233279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc is an erythropoietin early response gene in normal erythroid cells: evidence for a protein kinase C-mediated signal.
    Spangler R; Sytkowski AJ
    Blood; 1992 Jan; 79(1):52-7. PubMed ID: 1728320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases.
    Nixon JS; Wilkinson SE; Davis PD; Sedgwick AD; Wadsworth J; Westmacott D
    Agents Actions; 1991 Mar; 32(3-4):188-93. PubMed ID: 1650519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C inhibitor H-7 alters the actin cytoskeleton of cultured cells.
    Birrell GB; Hedberg KK; Habliston DL; Griffith OH
    J Cell Physiol; 1989 Oct; 141(1):74-84. PubMed ID: 2777903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of protein kinase inhibitor (1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) on protein kinase C activity and adrenergic stimulation of cAMP and cGMP in rat pinealocytes.
    Ho AK; Chik CL; Klein DC
    Biochem Pharmacol; 1988 Mar; 37(6):1015-20. PubMed ID: 2833269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential effects of protein kinase C activators and inhibitors on rat anterior pituitary hormone release.
    Thomson FJ; Johnson MS; Mitchell R; Wolbers WB; Ison AJ; MacEwan DJ
    Mol Cell Endocrinol; 1993 Aug; 94(2):223-34. PubMed ID: 8224525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C.
    Sozzani S; Agwu DE; McCall CE; O'Flaherty JT; Schmitt JD; Kent JD; McPhail LC
    J Biol Chem; 1992 Oct; 267(28):20481-8. PubMed ID: 1328200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
    Stockwin LH; Yu SX; Stotler H; Hollingshead MG; Newton DL
    BMC Cancer; 2009 Feb; 9():63. PubMed ID: 19232100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new biological role of sangivamycin; inhibition of protein kinases.
    Osada H; Sonoda T; Tsunoda K; Isono K
    J Antibiot (Tokyo); 1989 Jan; 42(1):102-6. PubMed ID: 2921215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.